Delfraissy J F, Tchernia G, Laurian Y, Wallon C, Galanaud P, Dormont J
Br J Haematol. 1985 Jun;60(2):315-22. doi: 10.1111/j.1365-2141.1985.tb07417.x.
Intravenous gammaglobulin (IVIgG) was given to seven adults with chronic idiopathic thrombocytopenic purpura (ITP). In parallel with platelet count, we studied Con A induced suppressor cell function for the autologous in vitro B cell response, T cell subsets and PAIgG levels, immediately before and 3-4 d after completion of treatment. Before treatment all patients had normal T cell subsets, decreased T suppressor cell function and increased levels of PAIgG. After IVIgG infusions, two patients were unresponsive and neither suppressor cell function nor PAIgG levels varied. In contrast, in the five responding patients we found an improvement in suppressor cell function and a decrease in PAIgG levels, while T cell subsets remained unmodified. Such results were reproducible in three patients after a second series of gammaglobulin infusions. Our results support the hypothesis that IVIgG infusion, apart from its effects on the reticuloendothelial system, may modulate the immune response by enhancing suppressor T cell function.
对7名患有慢性特发性血小板减少性紫癜(ITP)的成年人给予静脉注射丙种球蛋白(IVIgG)。在治疗前及治疗结束后3 - 4天,我们在监测血小板计数的同时,研究了刀豆蛋白A诱导的针对自体体外B细胞反应的抑制细胞功能、T细胞亚群和PAIgG水平。治疗前,所有患者的T细胞亚群均正常,T抑制细胞功能降低,PAIgG水平升高。静脉注射IVIgG后,2例患者无反应,抑制细胞功能和PAIgG水平均无变化。相比之下,在5例有反应的患者中,我们发现抑制细胞功能有所改善,PAIgG水平降低,而T细胞亚群保持不变。在进行第二轮丙种球蛋白输注后,3例患者出现了同样的结果。我们的结果支持这样的假设,即静脉注射IVIgG除了对网状内皮系统有影响外,还可能通过增强抑制性T细胞功能来调节免疫反应。